サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413379

呼吸器感染症診断薬市場：検査、疾患、エンドユーザー別-2024-2030年の世界予測

Respiratory Infection Diagnostics Market by Test (Antigen Detection Assays, Direct Fluorescent Antibody Tests, Imaging Tests), Disease (Asthma, Chronic Obstructive Pulmonary Disease, Coronavirus Infections), End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
呼吸器感染症診断薬市場：検査、疾患、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

呼吸器感染症診断薬市場規模は2023年に769億4,000万米ドルと推計され、2024年には823億5,000万米ドルに達し、CAGR 7.15%で2030年には1,247億8,000万米ドルに達すると予測されます。

世界の呼吸器感染症診断薬市場

主な市場の統計
基準年[2023］ 769億4,000万米ドル
予測年[2024] 823億5,000万米ドル
予測年 [2030] 1,247億8,000万米ドル
CAGR（%） 7.15%
呼吸器感染症診断薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは呼吸器感染症診断薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、呼吸器感染症診断薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-呼吸器感染症診断薬市場の市場規模および予測は？

2-呼吸器感染症診断薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-呼吸器感染症診断薬市場における技術動向と規制の枠組みは？

4-呼吸器感染症診断薬市場における主要ベンダーの市場シェアは？

5-呼吸器感染症診断薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性閉塞性肺疾患（COPD）の発生率の増加
      • ヘルスケアインフラの拡充と診断手順の利用可能性の向上
      • 感染症診断に対する政府資金の急増
    • 抑制要因
      • 診断とテストのコストが高く、償還シナリオが限られている
    • 機会
      • 気道感染症を診断するための次世代シーケンスベースのプラットフォームの利用可能性
      • 研究開発活動の拡大
    • 課題
      • 厳しい規制上の制約
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 呼吸器感染症診断薬市場テスト別

  • 抗原検出アッセイ
  • 直接蛍光抗体検査
  • 画像検査
    • CTスキャン
    • X線
  • 体外診断（IVD）検査
  • 核酸増幅検査
  • 迅速な診断テスト

第7章 呼吸器感染症診断薬市場：疾患別

  • 喘息
  • 慢性閉塞性肺疾患
  • コロナウイルス感染症
  • エンテロウイルス
  • インフルエンザ疾患
  • 肺がん
  • 肺炎
  • 結核
  • 百日咳（百日咳）

第8章 呼吸器感染症診断薬市場：エンドユーザー別

  • 臨床検査室
  • 病院

第9章 南北アメリカの呼吸器感染症診断薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の呼吸器感染症診断薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの呼吸器感染症診断薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • AccuBioTech Co. Ltd.
    • Atomo Diagnostics Ltd.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • bioMerieux SA
    • BIORON Diagnostics GmbH
    • Cardinal Health Inc.
    • Chembio Diagnostics, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Merck KGaA
    • Meridian Bioscience Inc. by SD Biosensor
    • Quest Diagnostics Incorporated
    • Quidel Corporation
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. RESPIRATORY INFECTION DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. RESPIRATORY INFECTION DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 8. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 10. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. RESPIRATORY INFECTION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. RESPIRATORY INFECTION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. RESPIRATORY INFECTION DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 6. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ANTIGEN DETECTION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DIRECT FLUORESCENT ANTIBODY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 10. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CT- SCAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD) TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 16. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CORONAVIRUS INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ENTEROVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFLUENZA DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY WHOOPING COUGH (PERTUSSIS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. RESPIRATORY INFECTION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 197. RESPIRATORY INFECTION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. RESPIRATORY INFECTION DIAGNOSTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-02026C4C8633

[186 Pages Report] The Respiratory Infection Diagnostics Market size was estimated at USD 76.94 billion in 2023 and expected to reach USD 82.35 billion in 2024, at a CAGR 7.15% to reach USD 124.78 billion by 2030.

Global Respiratory Infection Diagnostics Market

KEY MARKET STATISTICS
Base Year [2023] USD 76.94 billion
Estimated Year [2024] USD 82.35 billion
Forecast Year [2030] USD 124.78 billion
CAGR (%) 7.15%
Respiratory Infection Diagnostics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Respiratory Infection Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Respiratory Infection Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Infection Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co. Ltd., Atomo Diagnostics Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., bioMerieux SA, BIORON Diagnostics GmbH, Cardinal Health Inc., Chembio Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, Meridian Bioscience Inc. by SD Biosensor, Quest Diagnostics Incorporated, and Quidel Corporation.

Market Segmentation & Coverage

This research report categorizes the Respiratory Infection Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test
    • Antigen Detection Assays
    • Direct Fluorescent Antibody Tests
    • Imaging Tests
      • CT- Scan
      • X-ray
    • In Vitro Diagnostics (IVD) Tests
    • Nucleic Acid Amplification Tests
    • Rapid Diagnostic Tests
  • Disease
    • Asthma
    • Chronic Obstructive Pulmonary Disease
    • Coronavirus Infections
    • Enterovirus
    • Influenza diseases
    • Lung Cancer
    • Pneumonia
    • Tuberculosis
    • Whooping Cough (Pertussis)
  • End-User
    • Clinical Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Respiratory Infection Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Respiratory Infection Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Respiratory Infection Diagnostics Market?

4. What is the market share of the leading vendors in the Respiratory Infection Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Respiratory Infection Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Respiratory Infection Diagnostics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of chronic obstructive pulmonary disease (COPD)
      • 5.1.1.2. Increasing healthcare infrastructure coupled with the availability of diagnostic procedures
      • 5.1.1.3. Rapid rise in government funding towards infectious disease diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of diagnosis and testing limited reimbursement scenarios
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of next-generation sequencing-based platform to diagnose respiratory tract infections
      • 5.1.3.2. Expanding number of R&D activities
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory constraints
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Respiratory Infection Diagnostics Market, by Test

  • 6.1. Introduction
  • 6.2. Antigen Detection Assays
  • 6.3. Direct Fluorescent Antibody Tests
  • 6.4. Imaging Tests
    • 6.5.1. CT- Scan
    • 6.5.2. X-ray
  • 6.5. In Vitro Diagnostics (IVD) Tests
  • 6.6. Nucleic Acid Amplification Tests
  • 6.7. Rapid Diagnostic Tests

7. Respiratory Infection Diagnostics Market, by Disease

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. Chronic Obstructive Pulmonary Disease
  • 7.4. Coronavirus Infections
  • 7.5. Enterovirus
  • 7.6. Influenza diseases
  • 7.7. Lung Cancer
  • 7.8. Pneumonia
  • 7.9. Tuberculosis
  • 7.10. Whooping Cough (Pertussis)

8. Respiratory Infection Diagnostics Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinical Laboratories
  • 8.3. Hospitals

9. Americas Respiratory Infection Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Respiratory Infection Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Respiratory Infection Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. AccuBioTech Co. Ltd.
    • 13.1.3. Atomo Diagnostics Ltd.
    • 13.1.4. Becton, Dickinson and Company
    • 13.1.5. Bio-Rad Laboratories Inc.
    • 13.1.6. bioMerieux SA
    • 13.1.7. BIORON Diagnostics GmbH
    • 13.1.8. Cardinal Health Inc.
    • 13.1.9. Chembio Diagnostics, Inc.
    • 13.1.10. F. Hoffmann-La Roche Ltd.
    • 13.1.11. Hologic, Inc.
    • 13.1.12. Merck KGaA
    • 13.1.13. Meridian Bioscience Inc. by SD Biosensor
    • 13.1.14. Quest Diagnostics Incorporated
    • 13.1.15. Quidel Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing